TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Overall exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: alanine transaminase values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: aspartate aminotransferase values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: total bilirubin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Mean change in symptom scores from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative i.v. morphine consumption at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year graft and patient survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of gastric outlet obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for (re-)gastrojejunostomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: instability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with uninhibited bladder contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year survival improvement
Endpoint domain: Mortality/survival
Primary endpoint: survival time to the first cigarette smoked
Endpoint domain: Mortality/survival
Primary endpoint: unplanned hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: recurrent hospital costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average rate of progression of subclinical atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exercise blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived symptom limitation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First stroke
Endpoint domain: Mortality/survival
Primary endpoint: Disease activity at W14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar Tissue Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction Rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in symptoms (pain, fatigue, mood)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: MetHb bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: COHb bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of recovery from MDD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dropout rates from treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: successful rate of feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily gastric residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: LENT‐SOMA grade 2/3 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: mean effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: protection rate of plaster
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cough frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-worth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progress through stages of behavior change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dose of LST
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of thrombophilic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic hypertension prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal growth restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in children's snacking frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bond strengths of self-etch adhesive systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical course of the acute period of myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Remote forecast of myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Controlling allergy symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relieving sneezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual screening for albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annual monitoring for albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Avoidance of NSAIDs in patients with CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VASdural
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VASdural-24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of episiotomy procedures
Endpoint domain: Adverse events/effects
Primary endpoint: In-hospital death prediction accuracy
Endpoint domain: Mortality/survival
Primary endpoint: proportion of patients achieving normal serum Ca (≤10.3 mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduction in serum PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: increase in serum phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone marrow reticulin grade at diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rates of arterial thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Craving during use of Copenhagen
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Withdrawal symptom score during use of Copenhagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nicotine AUC and Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in alcohol-related interactional skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positivity of urine culture after flexible cystoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: incidence of autopleurodesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trait anxiety scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: tic outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall IBS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall improvement in QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: levels of sperm SH groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of spermatozoa with DD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: late thrombosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean stay in the ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma norepinephrine and arginine vasopressin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to return to baseline dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in inspiratory capacity (IC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACS rate
Endpoint domain: Mortality/survival
Primary endpoint: Gensini score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative risk reduction in stroke
Endpoint domain: Mortality/survival
Primary endpoint: Morning IGF-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Nocturnal growth hormone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Balance between nitrogen input and urinary urea nitrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of positive aspiration
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of failed blocks
Endpoint domain: Adverse events/effects
Primary endpoint: Pain experienced with injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intestinal cholesterol absorption efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fecal endogenous cholesterol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Billing rates for VCAI
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Billing rates for CAUTI
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of global EF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase of infarct wall movement velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Rrs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CSF levels of MDA, SOD, GPx and blood levels of vitamins A and E
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse outcome (death or neurologically abnormal at discharge)
Endpoint domain: Mortality/survival
Primary endpoint: Gingival irritation risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whitening effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: salivary bacterial viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean MTM distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological MTM distances achieving minimum MRI assessed distance
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of hypoesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of diuresis renography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specificity of diuresis renography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Accuracy of diuresis renography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in median SCORAD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: event-free interval
Endpoint domain: Mortality/survival
Primary endpoint: response to chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 emergence cough
Endpoint domain: Adverse events/effects
Primary endpoint: Cocaine-positive tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of illegal activity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: quality of life in NICU
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: pain threshold perceived by newborn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average life-years gained per patient
Endpoint domain: Mortality/survival
Primary endpoint: Beta diversity of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrichment of beneficial bacteria (Bifidobacterium and Lactobacillus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhancement of predicted metagenome function pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metformin plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Z score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Waking times
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: peak concentration of fluvoxamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration-time curve of fluvoxamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral clearance of fluvoxamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean days of rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: adverse effects
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Reversion to normoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PANSS general psychopathology sub-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of VZV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of pain and disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time taken off work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: cost per episode of LBP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: risk of renal malfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Compliance (CL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Compliance with underage alcohol sales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: language comprehension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional NSAIDs required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Emergence time from anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAS (Goal Attainment Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lactate-induced emotional responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Glenohumeral internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total rotation range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PST (Pain Sensitivity Threshold)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of opioid-induced cough
Endpoint domain: Adverse events/effects
Primary endpoint: Overall adverse event incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total scores at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Induction of anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical anaesthesia observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nociceptive withdrawal reflex scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: general fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Likelihood of response at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ipsilateral breast tumor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: locoregional control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 24-hour ambulatory systolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-hour ambulatory diastolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in serum ferritin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Non-inferiority to benchmark
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Preterm birth before 37 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Preterm birth at less than 34 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Individual needs and preferences met
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Median VL change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of ASL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of tumor resected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: effectiveness of resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: duration of EF applied
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: DRS-R-98 severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total orally-administered prednisolone in one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: admission duration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: annual weight increments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Forearm volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sprint speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemia awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe hypoglycemia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBF and a* values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of patients recovered by day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean stool frequency on day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: weight gain at days 7 and 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to proper response to verbal command
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to stating one's name
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total post-operative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HDL cholesterol efflux capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mortality within 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of retching and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: number of chest compressions per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minute volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial fibrillation symptom burden scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interventricular septal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical effectiveness of botulinum toxin + standard care vs standard care alone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nicotine dependence levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative volume of blood transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes